These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 653788)

  • 41. Dermal leishmaniasis simulating leprosy; case notes.
    CHAKRAVARTY AN; BHATTACHARYYA AK
    Calcutta Med J; 1951 Jul; 48(7):227-9. PubMed ID: 14879253
    [No Abstract]   [Full Text] [Related]  

  • 42. Neurofibromatosis and leprosy.
    Swift TR
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):743-9. PubMed ID: 5003511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse leprosy of Lucio and Latapí: a histologic study.
    Vargas-Ocampo F
    Lepr Rev; 2007 Sep; 78(3):248-60. PubMed ID: 18035776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymphocyte transformation test in healthy contacts of patients with leprosy. II. Influence of consanguinity with the patient, sex, and age.
    Menzel S; Bjune G; Kronvall G
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):153-9. PubMed ID: 378872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recognition of Mycobacterium leprae antigens with antibodies present in sera from patients with lepromatous leprosy.
    Islas-Rodríguez AE; Guillén-Vargas CM; Fafutis-Morris M; Alfaro-Bustamante F; Morales-Ortíz R; Gonzalez-Mendoza A; Estrada-Parra I
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):245-9. PubMed ID: 7690388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Current status of leprosy].
    Bourée P; de Carsalade GY
    Rev Prat; 2012 Jun; 62(6):751-5. PubMed ID: 22838263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [2 infectious granulomatous diseases (leprosy and cutaneous and mucous leishmaniasis) by scintigraphic methods].
    Braga FJ; Abreu CM; Abreu PR; Camargo EE; Rivitti MC; Tedesco-Marchesi LC; Gambini DJ; Barritault L
    Bull Soc Pathol Exot; 1992; 85(1):53-6. PubMed ID: 1596960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
    Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A
    Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leishmania (Kinetoplastida): species typing with isoenzyme and PCR-RFLP from cutaneous leishmaniasis patients in Ethiopia.
    Gadisa E; Genetu A; Kuru T; Jirata D; Dagne K; Aseffa A; Gedamu L
    Exp Parasitol; 2007 Apr; 115(4):339-43. PubMed ID: 17083934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of cutaneous cell-mediated immune response to rIFN gamma on Mycobacterium leprae viability in the lesions of lepromatous leprosy.
    Damasco MH; Sarno EN; Lobão AS; Alvarenga FB; Porto JA; Rosankaimer F; Kaplan G
    Braz J Med Biol Res; 1992; 25(5):457-65. PubMed ID: 1342221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin granuloma in the Nile Valley.
    el Mofty AM; Nada MM
    Int J Dermatol; 1970; 9(1):33-40. PubMed ID: 5425322
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T; Myklestad B; Samuel DR; Myrvang B
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lepromatous leprosy presenting with polyarthritis, myositis, and immune-complex glomerulonephritis.
    Iveson JM; McDougall AC; Leathem AJ; Harris HJ
    Br Med J; 1975 Sep; 3(5984):619-21. PubMed ID: 126102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laryngeal involvement causing dysphonia in a 29 year old nursing mother with lepromatous leprosy.
    Fwoloshi S; Machona SM; Mudenda V; Ngalamika O
    Pan Afr Med J; 2015; 21():146. PubMed ID: 26327983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The diagnostic challenge of mapping elephantiasis in the Tigray region of northern Ethiopia.
    Padovese V; Marrone R; Dassoni F; Vignally P; Barnabas GA; Morrone A
    Int J Dermatol; 2016 May; 55(5):563-70. PubMed ID: 26518364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IMMUNOLOGICAL IDENTIFICATION OF FOOT-PAD ISOLATES AS MYCOBACTERIUM LEPRAE BY LEPROMIN REACTIVITY IN LEPROSY PATIENTS.
    SHEPARD CC; GUINTO RS
    J Exp Med; 1963 Aug; 118(2):195-204. PubMed ID: 14074384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.